Cargando…
Cerebral infarction 3 weeks after intravenous immunoglobulin for Miller Fisher syndrome: a case report
INTRODUCTION: Intravenous immunoglobulin is considered generally safe and is used widely as proven, and sometimes empiric, treatment for an expanding list of autoimmune diseases. Thromboembolic complications following intravenous immunoglobulin therapy are rare and there have been only five previous...
Autores principales: | Chang, Thashi, de Alwis, Johann Shenoj, Samarasekara, Neirosha, Rajapakse, Senaka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4007143/ https://www.ncbi.nlm.nih.gov/pubmed/24661403 http://dx.doi.org/10.1186/1752-1947-8-100 |
Ejemplares similares
-
Acute Bilateral Ophthalmoparesis with Pupilary Areflexical Mydriasis in Miller-Fisher Syndrome Treated with Intravenous Immunoglobulin
por: Papanikolaou, Theocharis, et al.
Publicado: (2010) -
Pediatric Miller Fisher Syndrome; Characteristic Presentation and Comparison with Adult Miller Fisher Syndrome
por: Jang, Yeonji, et al.
Publicado: (2020) -
Recurrent Miller Fisher Syndrome
por: Ooi, Say Ting, et al.
Publicado: (2022) -
Miller Fisher syndrome with sinus arrest
por: Shiraiwa, Nobuko, et al.
Publicado: (2017) -
Miller Fisher syndrome developing as a parainfectious manifestation of dengue fever: a case report and review of the literature
por: de Silva, Nipun Lakshitha, et al.
Publicado: (2019)